Amelioration of Adverse Ocular Side Effects of Glaucoma Medications in Glaucoma Patients Using Topical GL101

Clinical trial NCT02656394 · COMPLETED

Trial details

NCT number: NCT02656394
Sponsor: Glia, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ocular Surface Disease

Start date: 2016-01-22
Primary completion: 2017-12-04
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.